Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Talis Biomedical (TLIS)
NASDAQ:TLIS
Talis Biomedical (TLIS) Stock Price & Analysis
41 Followers
TLIS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.35 - $9.60
Previous Close$8.5
Volume326.00
Average Volume (3M)7.35K
Market Cap
$269.33M
Enterprise Value$218.23M
Total Cash (Recent Filing)$70.34M
Total Debt (Recent Filing)$19.24M
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Aug 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-31.43
Shares Outstanding1,822,153
10 Day Avg. Volume7,062
30 Day Avg. Volume7,350
Standard Deviation0.18
R-Squared0.21
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.20
Price to Sales (P/S)39.19
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.46K
Enterprise Value/Gross Profit-5.32K
Enterprise Value/Ebitda-3.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Talis Biomedical News
PremiumCompany Announcements
Talis Biomedical Secures Interim CFO Amidst Corporate Changes
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TLIS FAQ
What was Talis Biomedical’s price range in the past 12 months?
Talis Biomedical lowest stock price was $4.35 and its highest was $9.60 in the past 12 months.
What is Talis Biomedical’s market cap?
Currently, no data Available
When is Talis Biomedical’s upcoming earnings report date?
Talis Biomedical’s upcoming earnings report date is Aug 07, 2024 which is in 19 days.
How were Talis Biomedical’s earnings last quarter?
Talis Biomedical released its earnings results on May 07, 2024. The company reported -$7.154 earnings per share for the quarter, missing the consensus estimate of N/A by -$7.154.
Is Talis Biomedical overvalued?
According to Wall Street analysts Talis Biomedical’s price is currently Overvalued.
Does Talis Biomedical pay dividends?
Talis Biomedical does not currently pay dividends.
What is Talis Biomedical’s EPS estimate?
Talis Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Talis Biomedical have?
Talis Biomedical has 1,822,153 shares outstanding.
What happened to Talis Biomedical’s price movement after its last earnings report?
Talis Biomedical reported an EPS of -$7.154 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.528%.
Which hedge fund is a major shareholder of Talis Biomedical?
Among the largest hedge funds holding Talis Biomedical’s share is Baker Bros Advisors LP. It holds Talis Biomedical’s shares valued at 4M.
---
Talis Biomedical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.73%
12-Months-Change
Fundamentals
Return on Equity
-68.59%
Trailing 12-Months
Asset Growth
-38.00%
Trailing 12-Months
Company Description
Talis Biomedical
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
---
TLIS Company Deck
---
TLIS Earnings Call
Q2 2023
0:00 / 0:00
---
TLIS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---